Key facts
- This page summarizes Barry D. Quart's Form 3 filing for Connect Biopharma Holdings Ltd (CNTB).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 16 Mar 2026, 16:47.
Barry D. Quart - 16 Mar 2026 Form 3 Insider Report for Connect Biopharma Holdings Ltd (CNTB)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- CNTB
- Reported as of
- 16 Mar 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 16 Mar 2026, 16:47:00 UTC
- Prior SEC filing
- 12 Feb 2026
- Next SEC filing
- 08 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lisa Peraza attorney-in-fact for Barry D Quart
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Barry D. Quart filed Form 3 for Connect Biopharma Holdings Ltd (CNTB) on 16 Mar 2026.
Change
- Previous filing in this sequence was filed on 12 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001384243
Primary reporting owner
Quart Barry D
- Relationship
- Chief Executive Officer, Director
- Address
- 3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
- Signature
- /s/ Lisa Peraza attorney-in-fact for Barry D Quart
- Signature date
- 16 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CNTB
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 95,147
- Date
- 16 Mar 2026
- Ownership
- Direct
CNTB
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 128,887
- Date
- 16 Mar 2026
- Ownership
- By Joint Account with Spouse
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CNTB
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 16 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 2,658,734
- Exercise price
- $1.77
- Footnotes
- F1
CNTB
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 16 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 432,392
- Exercise price
- $0.9700
- Footnotes
- F1
CNTB
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 16 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 700,000
- Exercise price
- $2.69
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The stock option vests and becomes exercisable over four years, with 25% vesting on the first anniversary of the date of grant, and then with respect to the remaining shares on a ratable monthly basis over the next three years, subject to continuous service with the Company as of each applicable vesting date.
Footnote F2
The stock option vests and becomes exercisable on a ratable monthly basis over four years, subject to continuous service with the Company as of each applicable vesting date.